Clinical Trial Update: Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating sunitinib and/or nivolumab with chemotherapy in advanced soft tissue and bone sarcomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• OPDIVO (nivolumab)
• Sutent (sunitinib)

Snippet

Sponsor: Grupo Espanol de Investigacion en Sarcomas | Conditions: Soft Tissue Sarcoma, Bone Sarcoma | Phase 1, Phase 2 | Status: COMPLETED